Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LOQTEQ® Antibacterial Pre-Market Study Randomized, Controlled, Subject-blinded, Multi-center Study of LOQTEQ® Antibacterial Locking Plates in Subjects With Fractures of the Distal Fibula

NCT05260463 is registered in ClinicalTrials.gov with aap Implantate AG as lead sponsor.

NCT NCT05260463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05260463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LOQTEQ® Antibacterial Pre-Market Study Randomized, Controlled, Subject-blinded, Multi-center Study of LOQTEQ® Antibacterial Locking Plates in Subjects With Fractures of the Distal Fibula
Lead sponsor
aap Implantate AG
Phase
Not applicable
Overall status
Completed
Start date
December 9, 2021
Completion date
August 4, 2025
Enrollment
203 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

fracture of fibula, fractures, closed, fractures, open, surgical site infection